Is aspirin resistance due to noncompliance? - Reply

Archives of Internal Medicine

Volumn 168, Issue 5, 2008, Pages 550-

  Snoep, Jaapjan D ^a   Hovens, Marcel M C ^b   Eikenboom, Jeroen C J ^b   Van Der Bom, Johanna G ^b   Huisman, Menno V ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; THROMBOXANE B2;

ASPIRIN RESISTANCE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORRELATION ANALYSIS; DRUG MECHANISM; DRUG RESISTANCE; HUMAN; LETTER; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECURRENT DISEASE; STATISTICAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 42249110060     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Snoep JD, Hovens MMC, Eikenboom JCJ, van der Bom JG, Huisman MV. Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis. Arch Intern Med. 2007;167(15):1593-1599.
2. Cattaneo M. Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection. J Thromb Haemost. 2007;5(suppl 1):230-237.
3. Hovens MMC, Snoep JD, Eikenboom JCJ, van der Bom JG, Mertens BJA, Huisman MV. Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review. Am Heart J. 2007;153(2):175-181.